AbCellera Biologics Income Statement (2020-2025) | ABCL

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 4.66M11.23M9.36M207.91M202.74M27.64M5.51M139.33M316.58M45.92M101.38M21.55M12.19M10.06M6.60M9.18M
Gross Profit 4.22M10.68M8.74M182.38M182.73M24.03M4.29M117.44M271.94M40.71M86.35M20.01M8.42M6.21M3.13M6.08M
Operating items
Depreciation & Amortization - Total 1.40M2.30M2.50M2.79M2.90M3.00M3.10M3.90M
Research & Development 4.12M9.14M7.50M8.64M12.35M15.05M17.45M17.21M26.37M26.68M26.58M28.25M52.65M36.47M37.92M48.62M
Selling, General & Administrative 1.65M1.50M2.97M5.79M6.42M11.20M11.27M12.89M14.27M14.41M13.79M13.02M15.13M15.52M14.37M15.97M
Other Operating Expenses 1.01M1.44M0.67M32.70M25.89M8.43M4.88M27.68M49.60M10.92M20.77M15.28M6.38M6.45M6.10M6.74M
Operating Expenses 6.78M12.08M11.13M47.13M44.67M34.68M33.60M57.78M91.63M54.31M63.65M59.32M77.07M61.45M61.49M75.23M
Operating Income -2.12M-0.85M-1.77M160.78M158.07M-7.03M-28.10M81.55M224.95M-8.40M37.73M-37.78M-64.87M-51.39M-54.89M-66.05M
EBIT -2.12M-0.85M-1.77M160.78M158.07M-7.03M-28.10M81.55M224.95M-8.40M37.73M-37.78M-64.87M-51.39M-54.89M-66.05M
Non-operating items
Interest & Investment Income 0.67M1.41M5.56M8.47M9.76M10.78M10.74M10.97M
Other Non Operating Income 1.03M7.85M-2.26M-1.90M3.15M4.65M4.38M5.31M5.19M1.53M2.15M1.68M3.59M4.58M2.83M3.38M
Non Operating Income -1.00M7.56M-2.26M-13.47M3.41M4.96M3.12M3.16M5.86M1.51M8.85M6.37M16.73M13.38M15.61M17.45M
Net income details
EBT -2.09M6.70M-2.69M161.16M161.49M-2.07M-24.97M84.71M230.81M-6.89M46.59M-31.41M-48.15M-38.00M-39.28M-48.60M
Tax Provisions 44.27M0.25M-3.59M24.76M62.24M-0.10M19.96M-1.52M-8.04M-7.48M-10.67M-1.45M
Profit After Tax -2.09M6.70M-2.69M117.00M117.22M-2.32M-21.38M59.95M168.57M-6.79M26.62M-29.89M-40.11M-30.53M-28.61M-47.15M
Income from Continuing Operations -2.09M6.70M-2.69M161.16M117.22M-2.32M-21.38M59.95M168.57M-6.79M26.62M-29.89M-40.11M-30.53M-28.61M-47.15M
Consolidated Net Income -2.09M6.70M-2.69M161.16M117.22M-2.32M-21.38M59.95M168.57M-6.79M26.62M-29.89M-40.11M-30.53M-28.61M-47.15M
Income towards Parent Company -2.09M6.70M-2.69M161.16M117.22M-2.32M-21.38M59.95M168.57M-6.79M26.62M-29.89M-40.11M-30.53M-28.61M-47.15M
Net Income towards Common Stockholders -2.09M6.70M-2.69M117.00M117.22M-2.32M-21.38M59.95M168.57M-6.79M26.62M-29.89M-40.11M-30.53M-28.61M-47.15M
Additional items
EPS (Basic) -0.010.03-0.020.520.43-0.01-0.080.220.59-0.020.09-0.10-0.14-0.11-0.10-0.17
EPS (Weighted Average and Diluted) -0.010.03-0.020.440.37-0.01-0.080.190.54-0.020.08-0.10-0.14-0.11-0.10-0.17
Shares Outstanding (Weighted Average) 265.95M265.95M265.95M265.95M269.50M270.93M278.70M281.58M283.92M284.54M285.14M286.10M287.69M288.73M289.36M290.17M292.78M294.05M294.67M295.37M297.99M298.48M298.83M
Shares Outstanding (Diluted Average) 311.48M313.36M315.82M287.77M288.91M289.50M
EBITDA -2.12M-2.09M-2.69M117.00M117.22M-0.17M-22.89M59.58M169.08M-7.00M25.33M-30.57M-40.74M-30.41M-28.17M-47.41M
Shares Outstanding 152.22M152.52M154.09M270.93M276.98M281.15M284.52M285.05M285.76M288.43M289.19M289.78M293.62M294.67M295.16M298.36M298.65M299.01M
Tax Rate 27.4114.3829.2326.961.4742.854.8416.6919.6727.162.99